RE:RE:RE:RE:Anyone want to guess at RBC's new target price?There may be some truth to that line of thinking and it is what the company is selling but count me skeptical based on 40+ years of experience. Obviously, I hope you and the company are right about that. If new institutional holders compel US analysts to pick up coverage fo the stock, that will be a nice benefit from the deal. But the cost is way too high and other lesser NASH firms have found much more attractive ways to do deals at better prices and resulting in better analysts covering them. There may be benefits in time but it will always be a deal that could have been done at a better time for a better price with better side benefits.
ggg088 wrote: In my understanding, @2.75 is the cost for the institutional investor, they must have done a comprehensive research about the THTX mangement team, operation,finance and R&D, they will have further understanding than retailer investors, because they ave more resources and want to make profit . So why this deal is a negative news? From the long term trend, the sp would be going up because more institutional investor will be involved in this business.